Hidemasa Matsuo

Corresponding Author Tadakazu Kondo Department of Hematology, Kobe City Medical Center General Hospital, Kobe, Hyogo, Japan Correspondence Tadakazu Kondo, Department of Hematology, Kobe City Medical Center General Hospital, 2-1-1 Minami-machi, Minatojima, Chuo-ku, Kobe, Hyogo 650-0047, Japan. Email: tadakazu@kuhp.kyoto-u.ac.jp Search for more papers by this author

Abstract Acute myeloid leukemia (AML) is a malignancy characterized by differentiation arrest of hematopoietic precursor cells. Differentiation therapy is effective for patients with acute promyelocytic leukemia; however, only a few effective differentiation therapies have been established for patients with other AML subtypes. In this study, seven benzimidazole anthelmintics were examined to determine the effects of differentiation on AML cells.